TYMS and hepatocellular carcinoma: It was reported that enhancement of TYMS is also related to a reduced risk of HCC through discouraging the misincorporation of uracil into DNA, and some HCC patients may be benefited from 5-Fluorouracil-based chemotherapy[55,56].